In human glioma, TrkB.T1 has been found to enhance PDGF-driven gliomas in vivo, and in vitro experiments have revealed that TrkB.T1 augments the persistence of PI3K and STAT3 signaling pathways, including pAkt and pS6rp [48]. The gene discussed is NTRK2; the disease is central nervous system cancer.